CME-Directory

Chair: Jean Klastersky, MD

Chairs: Mario Dicato, MD and Eric van Cutsem, MD Abstract Deadline: 24 February 2006

Chairs: Bart Barlogie, MD, PhD and Elias J. Anaissie, MD

Institutional Insights in Multiple Myeloma, provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease, and supportive care. Educational Objectives: At the completion of this program, the participants should be able to: 1. Identify the prognostic indicators and diagnostic approaches to multiple myeloma. 2. Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management. 3. Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.

Chair: Morton Coleman, MD Co-Chairs: John P. Leonard, MD, Ruben Niesvisky, MD, and Richard R. Furman, MD

Chairs: Martin J. van den Bent, MD, PhD and W.K. Alfred Yung, MD Abstract Deadline: 1 March 2006

This educational activity is specifically designed for medical and surgical oncologists, dermatologists, researchers and other physicians, physicians-in-training and other healthcare professionals interested in and/or involved in the care of patients with melanoma and its consequences. Chairs: Arnold Monto, MD and John Oxford, MD

Chair: Corey J. Langer, MD November 21 - 22, 2008 New York, New York, USA New York Marriott East Side

Chair: Ronald Feld, MD

Chair: Richard M. Goldberg, MD Co-Chair: Mace L. Rothenberg, MD